Product correctly added to cart.

discount label
Febuxostat-acyl-β-D-glucuronide
View 3D

Biosynth logo

Febuxostat-acyl-β-D-glucuronide

CAS: 1351692-92-6

Ref. 3D-MF44747

1mg
486.00 €
2mg
712.00 €
5mg
1,072.00 €
10mg
1,875.00 €
25mg
3,348.00 €
Estimated delivery in United States, on Tuesday 21 Jan 2025

Product Information

Name:
Febuxostat-acyl-β-D-glucuronide
Description:

Febuxostat is a drug that inhibits the enzyme xanthine oxidase, which is involved in the production of uric acid. The chronic use of this drug can lead to a decrease in serum uric acid levels, which is associated with lowering of blood pressure and prevention of kidney stones. Febuxostat has been shown to be effective in patients with polyarticular rheumatoid arthritis and allopurinol-induced gout. Side effects may include gastrointestinal discomfort, low dose-related hypertension, and cardiovascular complications. Febuxostat interacts with colchicine and other drugs that are metabolized through cytochrome P450 enzymes. This interaction may reduce the effectiveness of these drugs or increase their toxicity.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
492.5 g/mol
Formula:
C22H24N2O9S
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-MF44747 Febuxostat-acyl-β-D-glucuronide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".